WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 4'6801 Infant (under 12 months) mortality rate: 52
GDP / capita (US$): 10'5101 Child (under 5 years) mortality rate: 52

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 3'517  3'536  3'566  3'605  3'648  3'767  4'463  4'180 
Births 32  33  33  33  33  41  64  77 
Surviving infants 32  32  32  33  33  41  63  75 
Pop. less than 5 years 157  162  166  173  180  236  349  381 
Pop. less than 15 years 500  512  522  538  559  780  1'078  1'201 
Female 15-49 years 824  833  851  870  890  976  1'164  1'142 

Number of reported cases

(Click for retrospective incidence data for Bosnia and Herzegovina)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  133  1'677  3'000  22  43  512 
Mumps
ChartChart
  170  56  7'881  3'577 
Pertussis
ChartChart
  20  12  19  43  287 
Polio*
ChartChart
 
Rubella
ChartChart
  16  17  144 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bosnia and Herzegovina)
Vaccine year result method % card seen                                                
BCG 2010  99  MICS   91  97  95  98  96  93 
DTP1 2010  98  MICS   91  90  89  92  95  90 
DTP3 2010  92  MICS   91  78  82  86  92  85 
DTP4          72  72  74 
IPV1          87  87  93 
HepB_BD          99*  96  99  96 
HepB3          78  82  89  92  85 
Hib3          69  78  79  87 
JapEnc         
MCV1          68  83  89  94  80 
MCV2          78  88  92  94  74 
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2010  91  MICS   91  79  74  86  87  87 
Rota1         
RotaC         
RCV1          67  84  89 
TT2plus          92  93  94 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bosnia and Herzegovina)
BCG
ChartChart
  97  95  98  97  96  93 
DTP1
ChartChart
  90  89  92  94  95  90 
DTP3
ChartChart
  78  82  86  89  92  85 
HepB3
ChartChart
  78  82  89  91  92 
HepB_BD
ChartChart
 
Hib3
ChartChart
  69  78  79  83  87 
IPV1
  58  56 
MCV1
ChartChart
  83  83  89  92  94  80 
MCV2
ChartChart
  78  88  92  93  94  74 
PCV3
 
Pol3
ChartChart
  79  74  86  87  87  87 
RCV1
ChartChart
  83  83  89  92  94  80 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 43
From 80 to 89% 100
From 50 to 79% 100
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 6 years; Yes
DTaPHibIPV 2, 4, 6 months; No
DTaPIPV 5 years; No
DTwP 18 months; No
HepB_Adult Yes health care workers
HepB_Pediatric birth; 1-2, 6 months; No
Hib 18 months; No
Influenza_Adult Yes elderly, adults with chronic illness, health care workers and other risk groups
Influenza_Pediatric Yes children with chronic illness
MMR 12 months; 6 years; Yes
OPV 18 months; 6, 14 years; No
Pneumo_conj Yes risk groups
Td 14 years; No
TT 18 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  No    No  No  No 
What years does the MYP cover? number 2015-2019  2015-2019           
Nº of districts with microplans that include activities to raise immunization coverage number   10  17    10  10  18 

System performance

Total Nº districts in country number 17  142      18  18 
Nº districts with DTP3 coverage >=80% number 10  12  11      17  16 
% of districts with DTP3 coverage >=80% From 0 to 100% 143  71      94  89 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 18      39  33 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes    Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes    Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%           100   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes    Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.